The latest trading day saw Moderna (MRNA) settling at $245.81, representing a +1.54% change from its previous close.
11h
Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be ...
Moderna shares rose ahead of late-stage clinical trial results for intismeran autogene.The companies are preparing regulatory ...
Moderna (NASDAQ: MRNA) leaped into the spotlight during the early days of the pandemic, and that was because the up-and-coming biotech player had a solution to the problem: a vacc ...
The S&P 500 gained 2.4% and the Nasdaq Composite 4.3% between selection dates (September 10, 2026 – October 8, 2026), while ...
Die Vereinbarung senkt die Unsicherheit am Standort Taichung; der Arbeitskonflikt mit der Gewerkschaft in Taoyuan dauert an.
Sanofi has signed a global licensing and strategic collaboration agreement with ScionxBio to develop long-acting mRNA therapies using the TERA platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results